Leveraging innate cell engagers for lymphoma treatment
European Pharmaceutical Review
DECEMBER 28, 2023
These efficacy results, combined with the safety profile that allows patients to complete their treatment regimen, are extremely encouraging. AlloNK® is a cryopreserved, off-the-shelf, non-genetically modified, allogeneic cord blood-derived NK cell manufactured at large scale. NK cell immunotherapy: what’s next in clinical development?
Let's personalize your content